Biochanin A modulates cell viability, invasion, and growth promoting signaling pathways in HER-2-positive breast cancer cells

Journal of Oncology

Volumn , Issue , 2009, Pages

  Bhushan, Alok ^a   Sehdev, Vikas ^a   Lai, James C K ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOCHANIN A; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ANIMAL CELL; ARTICLE; ASSAY; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL INVASION; CELL VIABILITY; DRUG MECHANISM; EPITHELIUM CELL; FIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 77749271163     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2009/121458     Document Type: Article

References (68)

1. Cancer Facts and Figures,. American Cancer Society, 2008
2. Hussain S. A., Palmer D. H., Spooner D., Rea D. W., Molecularly targeted therapeutics for breast cancer BioDrugs 2007 21 4 215 224
3. Harris L., Fritsche H., Mennel R. et al., American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer Journal of Clinical Oncology 2007 25 33 5287 5312 (Pubitemid 350232263)
4. Hanahan D., Weinberg R. A., The hallmarks of cancer Cell 2000 100 1 57 70
5. Polyak K., On the birth of breast cancer Biochimica et Biophysica Acta 2001 1552 1 1 13
6. Doyle D. M., Miller K. D., Development of new targeted therapies for breast cancer Breast Cancer 2008 15 1 49 56
7. Silva C. M., Shupnik M. A., Integration of steroid and growth factor pathways in breast cancer: focus on signal transducers and activators of transcription and their potential role in resistance Molecular Endocrinology 2007 21 7 1499 1512
8. Peppercorn J., Perou C. M., Carey L. A., Molecular subtypes in breast cancer evaluation and management: divide and conquer Cancer Investigation 2008 26 1 1 10
9. Sorlie T., Perou C. M., Tibshirani R.et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proceedings of the National Academy of Sciences of the United States of America 2001 98 19 10869 10874
10. Rodenhuis S., Bontenbal M., van Hoesel Q. G. C. M.et al., Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer Annals of Oncology 2006 17 4 588 596
11. Yarden Y., Biology of HER2 and its importance in breast cancer Oncology 2001 61 supplement 2 1 13
12. Sternlicht M. D., Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis Breast Cancer Research 2006 8 1, article 201
13. Slamon D. J., Clark G. M., Wong S. G., Levin W. J., Ullrich A., McGuire W. L., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 1987 235 4785 177 182
14. Mincey B. A., Genetics and the management of women at high risk for breast cancer Oncologist 2003 8 5 466 473
15. Uauy R., Solomons N., Diet, nutrition, and the life-course approach to cancer prevention Journal of Nutrition 2005 135 12, supplement 2934S 2945S
16. Jones P. A., Baylin S. B., The fundamental role of epigenetic events in cancer Nature Reviews Genetics 2002 3 6 415 428
17. Parkin D. M., Cancers of the breast, endometrium and ovary: geographic correlations European Journal of Cancer and Clinical Oncology 1989 25 12 1917 1925
18. Society A. C., Cancer Facts and Figures 2006 American Cancer Society
19. Ziegler R. G., Hoover R. N., Pike M. C.et al., Migration patterns and breast cancer risk in Asian-American women Journal of the National Cancer Institute 1993 85 22 1819 1827
20. Doll R., Peto R., The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today Journal of the National Cancer Institute 1981 66 6 1191 1308
21. Willett W. C., Diet, nutrition, and avoidable cancer Environmental Health Perspectives 1995 103 supplement 8 165 170
22. Willett W. C., Diet and cancer Oncologist 2000 5 5 393 404
23. Cui X., Dai Q., Tseng M., Shu X.-O., Gao Y.-T., Zheng W., Dietary patterns and breast cancer risk in the Shanghai breast cancer study Cancer Epidemiology Biomarkers and Prevention 2007 16 7 1443 1448 (Pubitemid 47076876)
24. Do M. H., Lee S. S., Kim J. Y., Jung P. J., Lee M. H., Fruits, vegetables, soy foods and breast cancer in pre- and postmenopausal korean women: a case-control study International Journal for Vitamin and Nutrition Research 2007 77 2 130 141
25. Wu A. H., Yu M. C., Tseng C.-C., Stanczyk F. Z., Pike M. C., Dietary patterns and breast cancer risk in Asian American women American Journal of Clinical Nutrition 2009 89 4 1145 1154
26. Dai Q., Franke A. A., Yu H.et al., Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics Cancer Epidemiology Biomarkers and Prevention 2003 12 6 497 502
27. Iwasaki M., Inoue M., Otani T.et al., Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group Journal of Clinical Oncology 2008 26 10 1677 1683
28. Verheus M., van Gils C. H., Keinan-Boker L., Grace P. B., Bingham S. A., Peeters P. H. M., Plasma phytoestrogens and subsequent breast cancer risk Journal of Clinical Oncology 2007 25 6 648 655
29. Pop E. A., Fischer L. M., Coan A. D., Gitzinger M., Nakamura J., Zeisel S. H., Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis, and estrogenic outcomes in healthy postmenopausal women: a phase I clinical trial Menopause 2008 15 4 684 692
30. Balabhadrapathruni S., Thomas T. J., Yurkow E. J., Amenta P. S., Thomas T., Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells Oncology Reports 2000 7 1 3 12
31. Constantinou A. I., Krygier A. E., Mehta R. R., Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice American Journal of Clinical Nutrition 1998 68 6, supplement 1426S 1430S
32. Jin Z., MacDonald R. S., Soy isoflavones increase latency of spontaneous mammary tumors in mice Journal of Nutrition 2002 132 10 3186 3190
33. Katdare M., Osborne M., Telang N. T., Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells International Journal of Oncology 2002 21 4 809 815
34. Sakla M. S., Shenouda N. S., Ansell P. J., MacDonald R. S., Lubahn D. B., Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells Endocrine 2007 32 1 69 78
35. Kumar N. B., Cantor A., Allen K., Riccardi D., Cox C. E., The specific role of isoflavones on estrogen metabolism in premenopausal women Cancer 2002 94 4 1166 1174
36. Snyder R. D., Gillies P. J., Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells Environmental and Molecular Mutagenesis 2002 40 4 266 276
37. Michael McClain R., Wolz E., Davidovich A., Bausch J., Genetic toxicity studies with genistein Food and Chemical Toxicology 2006 44 1 42 55
38. Snyder R. D., Gillies P. J., Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids Food and Chemical Toxicology 2003 41 10 1291 1298
39. Moon Y. J., Brazeau D. A., Morris M. E., Effects of flavonoids genistein and biochanin A on gene expression and their metabolism in human mammary cells Nutrition and Cancer 2007 57 1 48 58
40. Johnson T. L., Lai M. B., Lai J. C., Bhushan A., Inhibition of cell proliferation and MAP kinase and Akt pathways in oral squamous cell carcinoma by genistein and biochanin A Evidence-Based Complementary and Alternative Medicine
41. Lacroix M., Leclercq G., Relevance of breast cancer cell lines as models for breast tumours: an update Breast Cancer Research and Treatment 2004 83 3 249 289
42. Zientek-Targosz H., Kunnev D., Hawthorn L.et al., Transformation of MCF-10A cells by random mutagenesis with frameshift mutagen ICR191: a model for identifying candidate breast-tumor suppressors Molecular Cancer 2008 7, article 51
43. Debnath J., Muthuswamy S. K., Brugge J. S., Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures Methods 2003 30 3 256 268
44. Ueda Y., Wang S., Dumont N., Yi J. Y., Koh Y., Arteaga C. L., Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor -induced cell motility Journal of Biological Chemistry 2004 279 23 24505 24513
45. Ross J. S., Fletcher J. A., Linette G. P.et al., The HER-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy Oncologist 2003 8 4 307 325
46. Soule H. D., Maloney T. M., Wolman S. R.et al., Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10 Cancer Research 1990 50 18 6075 6086
47. Petersen O. W., Ronnov-Jessen L., Howlett A. R., Bissell M. J., Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells Proceedings of the National Academy of Sciences of the United States of America 1992 89 19 9064 9068
48. Adeyinka A., Nui Y., Cherlet T., Snell L., Watson P. H., Murphy L. C., Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression Clinical Cancer Research 2002 8 6 1747 1753
49. Osaki M., Oshimura M., Ito H., PI3K-Akt pathway: its functions and alterations in human cancer Apoptosis 2004 9 6 667 676
50. Mita M. M., Mita A., Rowinsky E. K., Mammalian target of rapamycin: a new molecular target for breast cancer Clinical Breast Cancer 2003 4 2 126 137
51. Ahmed K. M., Cao N., Li J. J., HER-2 and NF- B as the targets for therapy-resistant breast cancer Anticancer Research 2006 26 6B 4235 4243
52. Chabottaux V., Noel A., Breast cancer progression: insights into multifaceted matrix metalloproteinases Clinical and Experimental Metastasis 2007 24 8 647 656
53. Moasser M. M., The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis Oncogene 2007 26 45 6469 6487
54. Su S.-J., Lai M.-D., Yeh T.-M., Chow N.-H., Overexpression of HER-2/neu enhances the sensitivity of human bladder cancer cells to urinary isoflavones European Journal of Cancer 2001 37 11 1413 1418
55. Akiyama T., Ishida J., Nakagawa S.et al., Genistein, a specific inhibitor of tyrosine-specific protein kinases Journal of Biological Chemistry 1987 262 12 5592 5595
56. Bernhard D., Schwaiger W., Crazzolara R., Tinhofer I., Kofler R., Csordas A., Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells Cancer Letters 2003 195 2 193 199
57. Pagliacci M. C., Spinozzi F., Migliorati G.et al., Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival European Journal of Cancer, Part A 1993 29 11 1573 1577
58. Rasbach K. A., Schnellmann R. G., Isoflavones promote mitochondrial biogenesis Journal of Pharmacology and Experimental Therapeutics 2008 325 2 536 543
59. Ragione F. D., Cucciolla V., Borriello A.et al., Resveratrol arrests the cell division cycle at S/G2 phase transition Biochemical and Biophysical Research Communications 1998 250 1 53 58
60. Messina M. J., Wood C. E., Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary Nutrition Journal 2008 7, article 17
61. Sivaraman V. S., Wang H.-Y., Nuovo G. J., Malbon C. C., Hyperexpression of mitogen-activated protein kinase in human breast cancer Journal of Clinical Investigation 1997 99 7 1478 1483
62. Xing C., Imagawa W., Altered MAP kinase (ERK1,2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to EGF Carcinogenesis 1999 20 7 1201 1208
63. Dunn K. L., Espino P. S., Drobic B., He S., Davie J. R., The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling Biochemistry and Cell Biology 2005 83 1 1 14
64. Pianetti S., Arsura M., Romieu-Mourez R., Coffey R. J., Sonenshein G. E., Her-2/neu overexpression induces NF- B via a PI3-kinase/Akt pathway involving calpain-mediated degradation of I B- that can be inhibited by the tumor suppressor PTEN Oncogene 2001 20 11 1287 1299
65. Pellikainen J. M., Ropponen K. M., Kataja V. V., Kellokoski J. K., Eskelinen M. J., Kosma V.-M., Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis Clinical Cancer Research 2004 10 22 7621 7628
66. Hsu J.-T., Hung H.-C., Chen C.-J., Hsu W.-L., Ying C., Effects of the dietary phytoestrogen biochanin A on cell growth in the mammary carcinoma cell line MCF-7 Journal of Nutritional Biochemistry 1999 10 9 510 517
67. Moon Y. J., Shin B. S., An G., Morris M. E., Biochanin A inhibits breast cancer tumor growth in a murine xenograft model Pharmaceutical Research 2008 25 9 2158 2163
68. Yang X., Edgerton S. M., Kosanke S. D.et al., Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice Cancer Research 2003 63 10 2425 2433